Safety and efficacy of nelarabine in children and young adults with relapsed or refractory T-lineage acute lymphoblastic leukaemia or T-lineage lymphoblastic lymphoma: results of a phase 4 study

导出原文传递

翻译打印收藏纠错

作者： Zwaan, Christian Michel ^[1] ; Kowalczyk, Jerzy ^[2] ; Schmitt, Claudine ^[3] ; Bielorai, Bella ^[4] ; Russo, Mark W. ^[5] ; Woessner, Mary ^[6] ; Ranganathan, Sulabha ^[7] ; Leverger, Guy

作者单位： Erasmus MC Sophia Childrens Hosp, Dept Paediat Oncol, Rotterdam, Netherlands ^[1] Armand Trousseau Hosp, AP HP, Dept Paediat Oncohaematol, Paris, France ^[2] Sheba Med Ctr, Dept Paediat Haematol Oncol & BMT, Ramat Gan, Israel ^[3] Childrens Hosp, Dept Haematol Oncology Paediat, Nancy, France ^[4] Med Univ Lublin, Dept Paediat Haematol Oncol & Transplantol, Lublin, Poland ^[5] Novartis Pharmaceut, E Hanover, NJ USA ^[6] Adaptimmune LLC, Philadelphia, PA USA ^[7]

关键词 nelarabine paediatric acute lymphoblastic leukaemia acute lymphoblastic lymphoma T-lineage

发布时间 2018-03-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交